These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21315742)

  • 1. Post stroke intervention: is the window widening?
    Zhan X; Kuczynski B; Sharp FR
    Neuropharmacology; 2011 May; 60(6):1000-2. PubMed ID: 21315742
    [No Abstract]   [Full Text] [Related]  

  • 2. Life after SAINT.
    Hallevi H; Aronowski J
    Int J Stroke; 2007 Nov; 2(4):241-2. PubMed ID: 18705923
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroprotection in acute ischemic stroke: are we there yet?
    Shuaib A
    Int J Stroke; 2006 May; 1(2):100-1. PubMed ID: 18706053
    [No Abstract]   [Full Text] [Related]  

  • 4. [Can the symptoms of stroke be limited?].
    Lindsberg PJ; Kaste M
    Duodecim; 1997; 113(18):1765-70. PubMed ID: 10892068
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating acute ischemic stroke.
    Fisher M; Bastan B
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting endothelin receptors for pharmacotherapy of ischemic stroke: current scenario and future perspectives.
    Kaundal RK; Deshpande TA; Gulati A; Sharma SS
    Drug Discov Today; 2012 Jul; 17(13-14):793-804. PubMed ID: 22406696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapies for acute ischemic stroke.
    Leker RR; Eichel R; Rafaeli G; Ben-Hur T
    Isr Med Assoc J; 2006 Nov; 8(11):788-92. PubMed ID: 17180832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
    Parsons MW
    Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.
    Furuichi Y; Maeda M; Matsuoka N; Mutoh S; Yanagihara T
    Exp Neurol; 2007 Mar; 204(1):138-46. PubMed ID: 17169359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke.
    Choi D
    Neurobiol Dis; 2000 Oct; 7(5):552-8. PubMed ID: 11042076
    [No Abstract]   [Full Text] [Related]  

  • 11. Future of neuroprotective drugs in doubt.
    Birmingham K
    Nat Med; 2002 Jan; 8(1):5. PubMed ID: 11786882
    [No Abstract]   [Full Text] [Related]  

  • 12. Ensuring patient safety in clinical trials for treatment of acute stroke.
    Becker KJ; Tirschwell DL
    JAMA; 2001 Dec; 286(21):2718-9. PubMed ID: 11730448
    [No Abstract]   [Full Text] [Related]  

  • 13. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
    Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional recovery after embolic stroke in rodents by activated protein C.
    Zlokovic BV; Zhang C; Liu D; Fernandez J; Griffin JH; Chopp M
    Ann Neurol; 2005 Sep; 58(3):474-7. PubMed ID: 16130108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone: a new therapeutic approach for the treatment of acute stroke.
    Kikuchi K; Kawahara K; Miyagi N; Uchikado H; Kuramoto T; Morimoto Y; Tancharoen S; Miura N; Takenouchi K; Oyama Y; Shrestha B; Matsuda F; Yoshida Y; Arimura S; Mera K; Tada K; Yoshinaga N; Maenosono R; Ohno Y; Hashiguchi T; Maruyama I; Shigemori M
    Med Hypotheses; 2010 Dec; 75(6):583-5. PubMed ID: 20728280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment strategies: intravenous thrombolysis, neuronal protection, and anti-reperfusion injury agents.
    Clark WM; Lutsep HL
    Neuroimaging Clin N Am; 1999 Aug; 9(3):465-73. PubMed ID: 10433639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
    Tanaka Y; Marumo T; Omura T; Yoshida S
    Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.